David Kugler is Vice President of Immunology at Cartography Biosciences; he partners with the Discovery, Platform and Development teams to advance novel targets to lead candidates. Most recently before joining Cartography he was a Scientific Director at Juno Therapeutics/Bristol-Myers Squibb focused on building autologous and allogeneic cell therapy programs and platforms. David completed his PhD studying immune regulation in the context of infectious disease at Johns Hopkins University in partnership with the National Institutes for Allergy and Infectious Disease. Outside of work, David spends time traveling with his family and exploring the outdoors.
Recent Posts
- Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors
- Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs
- Cartography Biosciences Expands Leadership Team with Appointment of Dan Rock, Ph.D., as Chief Scientific Officer to Advance Novel Oncology Programs into Clinic
- Cartography Biosciences and Nested Therapeutics: Diamonds in the rough
- Cartography Biosciences Expands Scientific Advisory Board with Leading Antibody and Bi-specific Experts
Recent Comments
No comments to show.